Developing a New Modality Using Targeted Therapeutic Discovery
White Paper Dec 17, 2020

For several years one of the hottest fields for academic research and industrial development has been the human microbiome. The microbes comprising an individual’s microbiome can be pathogenic or live in symbiosis with the human body. Due to the sheer masses of bacteria found on and inside of the body and the amount of research needed to study them, adequate software must be applied to store the huge amount of data generated.
Download this case study to find out how Vedanta Biosciences, Inc. utilized Thermo Scientific Core LIMS™ and Core ELN™ software to:
- Support efforts to develop the human microbiome into a new modality for drug development
- Track many aspects of the company’s bacterial library
- Produce a reservoir of data to support further downstream development
Related White Papers
Download this whitepaper to learn more about digital technologies and how they are used in research for multiple industries.
READ MOREDownload this whitepaper to learn more about digital transformation and how its use can affect workflows.
READ MOREDownload this whitepaper to understand more about how automated sample storage can aid in the research of COVID-19.
READ MORELike what you just read? You can find similar content on the communities below.
Drug Discovery Immunology & MicrobiologyTo personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free
LOGIN SUBSCRIBE FOR FREE